Speak directly to the analyst to clarify any post sales queries you may have.
Senior leaders responsible for healthcare procurement and operations face increasing complexity in the IV tubing sets and accessories market. Strategic, forward-looking choices are essential to optimize care delivery, regulatory compliance, and supply chain resilience in a rapidly evolving landscape.
Market Snapshot: IV Tubing Sets & Accessories Market Outlook
In 2024, the global IV tubing sets and accessories market reached USD 1.55 billion and is projected to grow to USD 1.64 billion by 2025, supported by a compound annual growth rate (CAGR) of 5.79% through 2032. Sustained investments into infusion technology and supply chain optimization are driving this trajectory. Healthcare institutions—including hospital systems, ambulatory care providers, and home health services—are increasingly prioritizing reliable, adaptive product offerings. In response, manufacturers have focused on modular device integration, compatible system upgrades, and workflow enhancements, making it possible to meet shifting compliance standards and advance patient care.
Scope & Segmentation: IV Tubing Sets & Accessories Market
- Product Type: Extension sets facilitate handling of complex therapeutic regimens; microbore tubing provides efficient administration of low-volume fluids; multi-lumen tubing enables multiple therapies in parallel; standard sets support routine care procedures across clinical environments.
- Material Type: Polyethylene presents flexible, budget-conscious selections; polyurethane meets diverse vascular access requirements; polyvinyl chloride is suited for intensive interventions; silicone ensures biocompatibility and tolerance for longer durations.
- End User: Ambulatory centers require fast, reliable supplies; clinics demand multi-therapy compatibility; home healthcare environments prioritize simple, safe usability; hospitals rely on robust, scalable systems for advanced patient management.
- Channel of Distribution: Hospital pharmacies maintain inventory control; supplier contracts and e-commerce channels underpin efficient procurement; retail pharmacies cater to smaller practices; wholesalers serve high-volume, multi-site providers.
- Application: Blood transfusion sets comply with specialized transfusion protocols; bolus sets expedite critical medication delivery; infusion systems address a spectrum of therapeutic needs; parenteral nutrition sets support individualized nutritional regimens.
- Geographic Coverage: Regional strategies vary based on regulatory climates and local infrastructure, requiring tailored approaches in North America, Latin America, Europe, Middle East and Africa, and Asia-Pacific to meet organizational and compliance priorities.
- Key Companies Analyzed: Leading companies such as Becton, Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, ICU Medical, Inc., Smiths Group plc, Cardinal Health, Inc., Teleflex Incorporated, and Nipro Corporation spearhead technical innovation and maintain supply chain credibility.
Key Takeaways for Senior Decision-Makers
- Adopting advanced infusion technology enhances care flexibility and supports operational efficiency in all healthcare settings.
- Continuous attention to changing manufacturing and sterility standards supports long-term compliance and safety objectives.
- Customizable IV configurations allow organizations to pivot resources swiftly as patient therapy protocols evolve.
- Interdisciplinary collaboration among engineering, clinical, and materials professionals streamlines system development, reducing adoption time and minimizing onboarding efforts.
- Sustainability practices increasingly influence procurement, impacting vendor evaluation, resource planning, and aligning with organizational sustainability objectives.
Tariff Impact on the Supply Chain
Forthcoming U.S. tariff revisions scheduled for early 2025 are prompting reassessment of procurement strategies and supplier geographies. Leaders are diversifying vendor relations and increasing domestic sourcing, safeguarding critical operations against regulatory shifts and ensuring supply continuity.
IV Tubing Sets & Accessories Market: Methodology & Data Sources
Methodology & Data Sources
Research is grounded in direct interviews with procurement and clinical leaders, augmented by industry surveys and aligned with prevailing sector dynamics, ensuring sound and actionable findings for executive decision-making.
Why This Report Matters
- Supports procurement and compliance leaders in proactively adjusting sourcing strategies to rapidly changing regulatory and market demands.
- Enables planning for operational resilience and integration of advanced infusion technologies aligned with healthcare standards.
- Guides executives to optimize processes and resource allocation for stronger competitive performance in a dynamic environment.
These insights equip health organizations to build agile procurement protocols, strengthen supply chains, and respond decisively as the IV tubing sets and accessories market develops.
Conclusion
Embracing technological advancement and systematic sourcing update empowers healthcare organizations to proactively manage the regulatory and operational changes shaping the IV tubing sets and accessories industry.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Companies Mentioned
The companies profiled in this IV Tubing Sets & Accessories market report include:- Becton, Dickinson and Company
- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Terumo Corporation
- ICU Medical, Inc.
- Smiths Group PLC
- Cardinal Health, Inc.
- Teleflex Incorporated
- Nipro Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 185 |
| Published | November 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 1.64 Billion |
| Forecasted Market Value ( USD | $ 2.43 Billion |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |


